S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Retained Earnings Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Retained Earnings
NT$1.6B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
11%
Y
YungShin Global Holding Corp
TWSE:3705
Retained Earnings
NT$2.7B
CAGR 3-Years
6%
CAGR 5-Years
15%
CAGR 10-Years
15%
Formosa Laboratories Inc
TWSE:4746
Retained Earnings
NT$2.8B
CAGR 3-Years
-5%
CAGR 5-Years
25%
CAGR 10-Years
27%
ScinoPharm Taiwan Ltd
TWSE:1789
Retained Earnings
NT$1.3B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
4%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Retained Earnings
NT$8.7B
CAGR 3-Years
101%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Standard Chem & Pharm Co Ltd
TWSE:1720
Retained Earnings
NT$3.3B
CAGR 3-Years
18%
CAGR 5-Years
17%
CAGR 10-Years
16%

See Also

What is SCI Pharmtech Inc's Retained Earnings?
Retained Earnings
1.6B TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Retained Earnings amounts to 1.6B TWD.

What is SCI Pharmtech Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
11%

Over the last year, the Retained Earnings growth was 4%. The average annual Retained Earnings growth rates for SCI Pharmtech Inc have been 9% over the past three years , 9% over the past five years , and 11% over the past ten years .

Back to Top